Is BioAdaptives Inc halal to invest in?

According to Musaffa's Shariah screening methodology, BioAdaptives Inc (BDPT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is BioAdaptives Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioAdaptives Inc using these criteria to determine its compliance status.

Can Muslims buy shares of BioAdaptives Inc?

Muslim investors may consider investing in BioAdaptives Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is BioAdaptives Inc classified as NOT COVERED?

Musaffa determines the Shariah status of BioAdaptives Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for BioAdaptives Inc updated?

The Shariah compliance status of BioAdaptives Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like BioAdaptives Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of BioAdaptives Inc?

You can check the latest Shariah compliance status of BioAdaptives Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BioAdaptives Inc. Stock Analysis BDPT

United States N/A Nano Cap

BioAdaptives, Inc. engages in marketing, investigating, and distributing natural plant and algal-based products that improve health and wellness for humans and animals. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2014-07-09. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.

Key Statistics of BioAdaptives Inc (BDPT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.01$0.01

Today's Open

$0.01

Volume

6035.00

P/E Ratio (TTM)

52 Week Range

$0.01$0.12

Market Cap

114.08K

Avg. Volume

50.46K

Dividend Yield

Financial Metrics & Statements of BioAdaptives Inc (BDPT)

FAQ's for BioAdaptives Inc (BDPT)

According to Musaffa’s Shariah screening methodology, BioAdaptives Inc (BDPT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.